The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2019
DOI: 10.1016/j.nec.2018.12.005
|View full text |Cite
|
Sign up to set email alerts
|

Vagus Nerve Stimulation for the Treatment of Epilepsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
94
1
4

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 136 publications
(115 citation statements)
references
References 64 publications
(102 reference statements)
0
94
1
4
Order By: Relevance
“…Although our study focused on acoustic‐voice metrics vs other measures like laryngeal stroboscopy, endoscopy, electromyography, or questionnaire‐based assessments, Lundy 78 reported increased jitter with increasing frequency of stimulation and Charous et al 79 showed that jitter and shimmer measures increased at rest and during VNS. González et al 80 cited four studies that included adverse effects of VNS on voice: hoarseness, cough, paresthesia, throat pain, dyspnea, headache, and infection when used for seizure control 68,81‐83 . Moreover, when data from these studies were combined to represent a total sample size of 546 participants, by far, the most prominent adverse effect was hoarseness (31.8%, 173.5/546), followed by paresthesia (9.3%, 50.8/546), cough (9.2%, 50.3/546), throat pain (8.3%, 45.3/546), dyspnea (8.1%, 35/432), headache (7.4%, 40.4/546), and infection (2.9%, 14.8/511) (see footnote ).…”
Section: Discussionmentioning
confidence: 99%
“…Although our study focused on acoustic‐voice metrics vs other measures like laryngeal stroboscopy, endoscopy, electromyography, or questionnaire‐based assessments, Lundy 78 reported increased jitter with increasing frequency of stimulation and Charous et al 79 showed that jitter and shimmer measures increased at rest and during VNS. González et al 80 cited four studies that included adverse effects of VNS on voice: hoarseness, cough, paresthesia, throat pain, dyspnea, headache, and infection when used for seizure control 68,81‐83 . Moreover, when data from these studies were combined to represent a total sample size of 546 participants, by far, the most prominent adverse effect was hoarseness (31.8%, 173.5/546), followed by paresthesia (9.3%, 50.8/546), cough (9.2%, 50.3/546), throat pain (8.3%, 45.3/546), dyspnea (8.1%, 35/432), headache (7.4%, 40.4/546), and infection (2.9%, 14.8/511) (see footnote ).…”
Section: Discussionmentioning
confidence: 99%
“…VNS is one of the most common neuromodulation-based therapies available. The VNS system consists of a battery-powered pulse generator implanted below the clavicle and a lead that is wrapped around the left vagus nerve in the carotid sheath [11]. Although complete seizure freedom with VNS insertion is rare, it is often beneficial in reducing seizure frequency and improving QOL [12].…”
Section: Discussionmentioning
confidence: 99%
“…NIs are used in neuroprosthetic systems aiming to restore sensorimotor function after damage to the nervous system, as well as in neuromodulation systems aiming to treat diseases through the alteration of regulatory neural signals. Applications of NIs implanted in the peripheral nervous system include: restoring movement after paralysis (1); creating prosthetic limbs with intuitive control and sensory feedback(2); and treating conditions such as bladder dysfunction(3), epilepsy(4), hypertension(5), as well as inflammatory and autoimmune disorders(6). Despite their potential benefits, widespread implementation of NIs in the peripheral nervous system still faces several obstacles, including damage to neural tissue, a lack of long-term stability, and low signal resolution(7).…”
Section: Introductionmentioning
confidence: 99%